LakeShore Biopharma Co Ltd (LSB)
0.6479
+0.03
(+5.35%)
USD |
NASDAQ |
Jun 28, 16:00
0.6125
-0.04
(-5.46%)
After-Hours: 20:00
LakeShore Biopharma Cash from Investing (Quarterly): -3.237M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -3.237M |
Date | Value |
---|---|
September 30, 2022 | -2.777M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.237M
Minimum
Sep 2023
-2.777M
Maximum
Sep 2022
-3.007M
Average
-3.007M
Median
Cash from Investing (Quarterly) Benchmarks
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -20.15M |
Cash from Financing (Quarterly) | 6.199M |
Free Cash Flow Per Share (Quarterly) | -0.2516 |
Free Cash Flow to Equity (Quarterly) | -27.08M |
Free Cash Flow to Firm (Quarterly) | -22.73M |